Table 2.
Characteristics of patients and DILs.
| Characteristics | Value | |
|---|---|---|
| Age (years) | Median (range) | 66 (56–82) |
| PSA (ng/mL) | Median (range) | 5.6 (3–10.6) |
| T stage | 2a | 10 |
| 2b | 1 | |
| 2c | 4 | |
| Gleason score | 6 | 4 |
| 7 | 10 | |
| 9 | 1 | |
| Location of DILb | 2aa | 4 |
| 3a | 1 | |
| 3pa | 3 | |
| 5a | 1 | |
| 5p | 2 | |
| 6a | 2 | |
| 6p | 2 | |
| 8p | 3 | |
| 9p | 1 | |
| 10p | 1 | |
| DIL volume (cc) | Median (range) | 1.3 (0.7–6.6) |
| Prostate volume (cc) | Median (range) | 46.2 (18.9–63.4) |
| DIL / prostate volume ratio | Median (range) | 0.03 (0.01–1.21) |
| PTV volume (cc) | Median (range) | 70.0 (28.8–88.0) |
DIL dominant intraprostatic lesion, PSA prostate specific antigen.
aOne patient had a single tumor involving both 2a and 3p segments.
bFour patients had two lesions in separate segments.